首页> 外文期刊>Clinical nuclear medicine >Incidental Metastatic Melanoma Identified on 68Ga-Prostate-Specific Membrane Antigen PET/CT for Metastatic Prostate Cancer
【24h】

Incidental Metastatic Melanoma Identified on 68Ga-Prostate-Specific Membrane Antigen PET/CT for Metastatic Prostate Cancer

机译:在68gA - 前列腺特异性膜抗原PET / CT中鉴定出偶然的转移性黑色素瘤,用于转移前列腺癌

获取原文
获取原文并翻译 | 示例
           

摘要

A 78-year-old man with a history of surgically treated prostate cancer and melanoma underwent Ga-68-prostate-specific membrane antigen (PSMA) PET/CT for biochemical recurrence of his prostate cancer. This revealed locoregionally recurrent prostate cancer and a separate PSMA-avid nodule in his left arm. Subsequent F-18-FDG PET/CT and excision confirmed this to be an in-transit melanoma metastasis. Prostate-specific membrane antigen PET/CT has become a widely used and valuable tool in the assessment of prostate cancer, particularly biochemically recurrent. Uptake of PSMA has been described in a multitude of different benign and malignant conditions, but it has only rarely been documented in melanoma.
机译:一个78岁的男子,具有手术治疗的前列腺癌和黑色素瘤的历史,接受了GA-68-前列腺特异性膜抗原(PSMA)PET / CT用于他前列腺癌的生化复发。 这揭示了局部转发前列腺癌和左臂中的单独的PSMA-Avid结节。 随后的F-18-FDG PET / CT和切除证实这是一个转运型黑色素瘤转移。 前列腺特异性膜抗原PET / CT已成为评估前列腺癌的广泛使用和有价值的工具,特别是生物化学性复发。 已经在多种不同的良性和恶性条件下描述了PSMA的摄取,但它仅在黑色素瘤中记录了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号